Mit dem Laden der Stellenanzeigen akzeptieren Sie die Datenschutzerklärung der BITE GmbH.
Mehr erfahren
Stellenanzeigen immer entsperren? Passen Sie Ihre Einstellungen an.
For the first time, the European Patent Office has revoked a CRISPR patent with an early priority in the CRISPR IP landscape for lack of inventive step. Previous EPO proceedings mainly focused on questions of priority.
The oral proceedings in this case were conducted as a video conference, the proceedings having a certain complexity in view of the number of parties involved. All parties were able to confirm at the end of the oral proceedings that there were no technical complications.
The revoked patent is owned by the US biotechnology company Sigma-Aldrich (Merck). Opposition was filed, among others, by BASF, represented by Patent Attorney Dr. Christine Cirl, LL.M. (Eisenführ Speiser Munich).
JUVE Patent reports here.
We are using the external services listed below throughout this website. These services can set cookies and they will learn about your IP address. They might use this information to follow your activities and identify you on the Web ("Tracking"). You may withdraw your consent to this at any time. For further information please read our privacy policy.